KMDA: Kamada Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 255.27
Book Value / Share n/a
Price / Book n/a
NCAV ($M) 68.47
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.07

Liquidity (mrq)
Quick Ratio 2.73
Current Ratio 4.84

Balance Sheet (mrq) ($M)
Current Assets 164.41
Assets 351.21
Liabilities 95.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
3 days ago 13G/A Phoenix Holdings Ltd. 7.20 -4.07
02-14 13G/A Gov Financial Holdings Ltd. 6.15 -1.76

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 6,661 28,943 23.01
2024-11-14 6,035 44,519 13.56
2024-11-13 21,342 87,258 24.46
2024-11-12 14,499 91,724 15.81
2024-11-11 6,849 55,981 12.23

(click for more detail)

Similar Companies
IRWD – Ironwood Pharmaceuticals, Inc. ITCI – Intra-Cellular Therapies, Inc.
JAZZ – Jazz Pharmaceuticals plc KNSA – Kiniksa Pharmaceuticals, Ltd.
KPTI – Karyopharm Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io